News & Press Releases
Rejecting 'Obamacare' has cost Texas over $8 billion and, advocates say, put poor people's health at risk
By E. Tammy Kim
LAREDO, Texas—In mid-May, 20-year-old Anissa Rangel's gums began to bleed. At first she assumed it was related to her gingivitis, but one morning, she woke up in the bedroom that she shares with three siblings and saw her gray nightshirt stained dark red across the shoulder. A month passed before she told her mother that something was wrong. By then, another symptom was visible: purple bruises on her arms and legs.
WASHINGTON—Miriam Harmatz, a senior health law attorney with Florida Legal Services, Inc. (FLS), has joined the National Health Law Program's (NHeLP) board of directors. NHeLP protects and advances the health care rights of low-income and underserved individuals.
By Jason Millman
If you've been wondering why the high cost of a new hepatitis C cure has ignited such a fierce public debate over the past few months, it's because more specialty drugs like Sovaldi are going to flood the market in coming years. This class of drugs accounted for less than 1 percent of all prescriptions in 2013, but about 25 percent of all prescription drug spending — and spending on specialty drugs is projected to increase 63 percent by 2016, according to Express Scripts.